4//SEC Filing
BORRMANN LEONARD R 4
Accession 0001256928-09-000014
CIK 0001168335other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 8:20 PM ET
Size
47.7 KB
Accession
0001256928-09-000014
Insider Transaction Report
Form 4
BORRMANN LEONARD R
Executive Vice President
Transactions
- Disposition from Tender
Common Stock
2009-02-25$22.00/sh−78$1,716→ 4,286.814 total - Disposition from Tender
Common Stock
2009-02-26$22.00/sh−807.107$17,756→ 3,479.707 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−879.707$19,354→ 2,600 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−930$20,469→ 1,670 total - Award
Common Stock
2009-02-25+6,800→ 6,800 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−2,415$53,130→ 0 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−215$4,732→ 385 total - Award
Common Stock
2009-02-25+1,525→ 1,525 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−546$12,017→ 979 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−4,369$96,118→ 0 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−1,345$29,603→ 2,415 total - Award
Common Stock
2009-02-25+3,600→ 3,600 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−2,313$50,886→ 0 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−556$12,232→ 0 total(indirect: By 401(k)) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−12,000→ 0 totalExercise: $23.00From: 2008-03-01Exp: 2014-03-01→ Common Stock (12,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−15,000→ 0 totalExercise: $33.72From: 2008-05-20Exp: 2014-05-20→ Common Stock (15,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−15,300→ 0 totalExercise: $38.20From: 2009-02-25Exp: 2015-05-26→ Common Stock (15,300 underlying) - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−1,670$36,740→ 0 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−2,431$53,506→ 4,369 total - Award
Common Stock
2009-02-25+3,760→ 3,760 total - Award
Common Stock
2009-02-25+600→ 1,400 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−385$8,470→ 0 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−979$21,538→ 0 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−1,287$28,327→ 2,313 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−85,000→ 0 totalExercise: $22.94From: 2009-02-25Exp: 2018-05-29→ Common Stock (85,000 underlying)
Footnotes (9)
- [F1]These shares were tendered to Rainforest Acquisition Inc. ("Purchaser") pursuant to Purchaser?s offer to purchase all of the outstanding shares of Advanced Medical Optics, Inc. (the "Issuer") at a cash purchase price of $22.00 per share, without interest, and subject to any required withholding taxes, subject to the terms described in the Offer to Purchase, filed with the SEC on January 27, 2009, as amended (the "Tender Offer"). Such shares were purchased by Purchaser pursuant to the Tender Offer on February 25, 2009.
- [F2]Includes an aggregate of 1,922.2686 shares of common stock acquired through the issuer's Employee Stock Purchase Plan through February 24, 2009.
- [F3]These shares were canceled pursuant to the Agreement and Plan of Merger, dated January 11, 2009, by and among Abbott Laboratories, Purchaser and the Issuer (the "Merger Agreement"), in exchange for the right to receive cash payment of $22.00 per share in cash (without interest and subject to any required withholding taxes) at the effective time of the merger.
- [F4]Shares withheld in satisfaction of tax obligations attributable to the lapse of restrictions on stock award or in satisfaction of tax withholding attributable to vesting and settlement of restricted stock units.
- [F5]The exempt restricted stock units (previously reported on Table II) vested in full and were settled for shares of Issuer Common Stock in accordance with the terms of the applicable equity plan. At the effective time of the merger, such shares were cancelled pursuant to the Merger Agreement in exchange for the right to receive cash payment of $22.00 per share in cash (without interest and subject to any required withholding taxes).
- [F6]This previously reported exempt stock option, which had vested as to 100% of the underlying shares in accordance with its terms, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 4,923 shares of Abbott Laboratories common stock at an exercise price of $56.06 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F7]This previously reported exempt stock option, which was to have vested ratably over the first four years from the date of grant, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 6,154 shares of Abbott Laboratories common stock at an exercise price of $82.19 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F8]This previously reported exempt stock option, which was to have vested ratably over the first four years from the date of grant, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 6,277 shares of Abbott Laboratories common stock at an exercise price of $93.11 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F9]This previously reported exempt stock option, which was to have vested ratably over the first four years from the date of grant, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 34,875 shares of Abbott Laboratories common stock at an exercise price of $55.92 per share, determined pursuant to a formula set forth in the Merger Agreement.
Documents
Issuer
ABBOTT MEDICAL OPTICS INC
CIK 0001168335
Entity typeother
Related Parties
1- filerCIK 0001358334
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 8:20 PM ET
- Size
- 47.7 KB